Biocryst Pharmaceuticals (BCRX) Return on Capital Employed Growth (3y) (2014 - 2026)
Biocryst Pharmaceuticals (BCRX) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | -7,701.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,701.00 |
| Mar 31, 2026 | -10,125.00 |
| Dec 31, 2025 | 15,305.00 |
| Sep 30, 2025 | 6,316.00 |
| Jun 30, 2025 | 6,141.00 |
| Mar 31, 2025 | 4,657.00 |
| Dec 31, 2024 | 5,421.00 |
| Sep 30, 2024 | 11,663.00 |
| Jun 30, 2024 | 8,896.00 |
| Mar 31, 2024 | 6,476.00 |
| Dec 31, 2023 | 8,861.00 |
| Mar 31, 2023 | 14,716.00 |
| Dec 31, 2022 | 21,215.00 |
| Sep 30, 2022 | 55,224.00 |
| Jun 30, 2022 | 16,279.00 |
| Mar 31, 2022 | 9,251.00 |
| Dec 31, 2021 | 5,197.00 |
| Sep 30, 2021 | -3,050.00 |
| Jun 30, 2021 | -686.00 |
| Mar 31, 2021 | -1,349.00 |